Purchase and Sale Agreement By and Between ADC Therapeutics SA and Entities Managed by HealthCare Royalty Management, LLC Dated as of August 25, 2021Purchase and Sale Agreement • August 26th, 2021 • ADC Therapeutics SA • Pharmaceutical preparations • New York
This PURCHASE AND SALE AGREEMENT, dated as of August 25, 2021 (this “Agreement”), is made and entered into by and between the entities managed by Healthcare Royalty Management, LLC, a Delaware limited liability company, identified on the signature pages of this Agreement and listed on Exhibit F (individually and collectively, the “Buyer”), and ADC Therapeutics SA, a Swiss société anonyme (the “Seller”).
FACILITY AGREEMENT dated as of April 24, 2020, as amended by the Limited Consent and Amendment, dated as of August 25, 2021 by and among ADC THERAPEUTICS SA, as the Borrower, the other Loan Parties party hereto from time to time, the Lenders and...Facility Agreement • August 26th, 2021 • ADC Therapeutics SA • Pharmaceutical preparations • New York
IF THE LOANS ISSUED UNDER THIS INSTRUMENT ARE CONSIDERED TO BE DEBT FOR U.S. FEDERAL INCOME TAX PURPOSES, SUCH LOANS WILL BE ISSUED WITH ORIGINAL ISSUE DISCOUNT FOR PURPOSES OF SECTION 1271 OF THE UNITED STATES INTERNAL REVENUE CODE OF 1986.
